These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34861657)

  • 1. LONGITUDINAL ANALYSIS OF DIABETIC CHOROIDOPATHY IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION USING WIDEFIELD SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.
    Russell JF; Zhou H; Shi Y; Shen M; Gregori G; Feuer WJ; Wang RK; Rosenfeld PJ
    Retina; 2022 Mar; 42(3):417-425. PubMed ID: 34861657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effects of Intravitreal Ranibizumab Compared With Panretinal Photocoagulation on Optical Coherence Tomography Measured Choroidal Thickness and Vascularity.
    Lee B; Josic K; Nittala MG; Velaga SB; Karamat A; Srinivas S; Corvi F; Singh G; Sadda S; Sun JK; Ip M;
    Transl Vis Sci Technol; 2024 Jul; 13(7):19. PubMed ID: 39058503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
    Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
    Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Obeid A; Su D; Patel SN; Uhr JH; Borkar D; Gao X; Fineman MS; Regillo CD; Maguire JI; Garg SJ; Hsu J
    Ophthalmology; 2019 Mar; 126(3):407-413. PubMed ID: 30077614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in choroidal vascular parameters following panretinal photocoagulation using enhanced-depth imaging optical coherence tomography in diabetic retinopathy.
    Mirshahi A; Fadakar K; Mirshahi R; Khalili Pour E; Ebrahimiadib N; Ghassemi F; Khojasteh H; Bazvand F; Ghods S; Riazi-Esfahani H; Faghihi H
    Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):459-469. PubMed ID: 34468831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M; Yamashita M; Ogata N
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Chorioretinal Parameters in Diabetic Retinopathy with or without Pan-Retinal Photocoagulation Using Ultrawide-Field Swept-Source Optical Coherence Tomography Angiography.
    Li F; Liu L; Rao CH; Gao J
    Ophthalmic Res; 2023; 66(1):538-549. PubMed ID: 36709752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.
    Russell JF; Al-Khersan H; Shi Y; Scott NL; Hinkle JW; Fan KC; Lyu C; Feuer WJ; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2020 May; 213():177-185. PubMed ID: 32006481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Vascular Endothelial Growth Factor and Panretinal Photocoagulation Use after Protocol S for Proliferative Diabetic Retinopathy.
    Azad AD; Chen EM; Hinkle J; Rayess N; Wu D; Eliott D; Mruthyunjaya P; Parikh R
    Ophthalmol Retina; 2021 Feb; 5(2):151-159. PubMed ID: 32693033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of subfoveal choroidal thickness after panretinal laser photocoagulation in diabetic retinopathy using swept-source optical coherence tomography.
    Eleiwa KT; Bayoumy A; Elhusseiny MA; Gamil K; Sharawy A
    Rom J Ophthalmol; 2020; 64(3):285-291. PubMed ID: 33367162
    [No Abstract]   [Full Text] [Related]  

  • 14. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
    Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
    Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in choroidal vascular parameters following pan-retinal photocoagulation using swept-source optical coherence tomography.
    Kim JT; Park N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jan; 258(1):39-47. PubMed ID: 31680197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular changes of the choroid and their correlations with visual acuity in diabetic retinopathy.
    Jing R; Sun X; Cheng J; Li X; Wang Z
    Front Endocrinol (Lausanne); 2024; 15():1327325. PubMed ID: 38464970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of panretinal photocoagulation on retina and choroid in diabetic retinopathy: An optical coherence tomography angiography study.
    Acar OPA; Onur IU
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103166. PubMed ID: 36261094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography.
    Shen M; Zhou H; Kim K; Bo Q; Lu J; Laiginhas R; Jiang X; Yan Q; Iyer P; Trivizki O; Shi Y; de Sisternes L; Durbin MK; Feuer W; Gregori G; Wang RK; Sun X; Wang F; Yu SY; Rosenfeld PJ
    Invest Ophthalmol Vis Sci; 2021 Dec; 62(15):5. PubMed ID: 34860239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in choroidal thickness in patients with diabetic retinopathy.
    Ohara Z; Tabuchi H; Nakakura S; Yoshizumi Y; Sumino H; Maeda Y; Kiuchi Y
    Int Ophthalmol; 2018 Feb; 38(1):279-286. PubMed ID: 28194551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.